Raiffeisen Bank International’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Hold
8,000
0.02% 348
2025
Q4
$1.37M Hold
8,000
0.02% 295
2025
Q3
$1.03M Hold
8,000
0.01% 331
2025
Q2
$857K Sell
8,000
-1,522
-16% -$165K 0.01% 299
2025
Q1
$1.17M Sell
9,522
-42
-0.4% -$5.48K 0.02% 264
2024
Q4
$1.18M Buy
+9,564
New +$1.13M 0.02% 257

Other funds holding JAZZ

Raiffeisen Bank International's JAZZ Position: Q1 2026 in Review

Raiffeisen Bank International held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 8,000 shares worth $1.47M. The position accounts for 0.02% of the portfolio, ranked #348.

Raiffeisen Bank International first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Raiffeisen Bank International held 8,000 shares of Jazz Pharmaceuticals worth $1.47M as of Q1 2026.
  • Raiffeisen Bank International left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.02% of Raiffeisen Bank International's portfolio in Q1 2026, its #348 holding.
  • Raiffeisen Bank International first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.